Skip to main content
Back to feed
MarketsSingle-sourceLow
2.0

Keros Therapeutics reports executive or director departure via 8-K filing

Keros Therapeutics has filed an 8-K form disclosing the departure of a director or officer, or changes to compensatory arrangements. The specific identity of the individual and the nature of the departure remain to be detailed in the full filing content.

SEC EDGAR 8-K Filingsabout 14 hours agoUSCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1

Intelligence Tags

#sec#8-k#corporate-governance#biotech

Entities

country
Source

Related signals

8 found